HomeCompareSYK vs MET

SYK vs MET: Dividend Comparison 2026

SYK yields 1.04% · MET yields 3.33%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SYK wins by $2.0K in total portfolio value· pulled ahead in Year 10
10 years
SYK
SYK
● Live price
1.04%
Share price
$326.10
Annual div
$3.40
5Y div CAGR
46.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.3K
Annual income
$8,282.98
Full SYK calculator →
MET
MET
● Live price
3.33%
Share price
$68.27
Annual div
$2.27
5Y div CAGR
23%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$41.3K
Annual income
$4,879.85
Full MET calculator →

Portfolio growth — SYK vs MET

📍 SYK pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSYKMET
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SYK + MET cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SYK pays
MET pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SYK
Annual income on $10K today (after 15% tax)
$88.62/yr
After 10yr DRIP, annual income (after tax)
$7,040.53/yr
MET
Annual income on $10K today (after 15% tax)
$282.63/yr
After 10yr DRIP, annual income (after tax)
$4,147.87/yr
At 15% tax rate, SYK beats the other by $2,892.66/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SYK + MET for your $10,000?

SYK: 50%MET: 50%
100% MET50/50100% SYK
Portfolio after 10yr
$42.3K
Annual income
$6,581.41/yr
Blended yield
15.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SYK right now

SYK
Analyst Ratings
1
Strong
35
Buy
14
Hold
Consensus: Buy
Price Target
$428.67
+31.5% upside vs current
Range: $390.00 — $469.00
Altman Z
4.0
Piotroski
5/9
MET
Analyst Ratings
24
Buy
8
Hold
Consensus: Buy
Price Target
$96.83
+41.8% upside vs current
Range: $90.00 — $101.00
Altman Z
0.1
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SYK buys
0
MET buys
8
PoliticianChamberTickerTypeAmountDate
Ro Khanna🏢 House$MET▲ Buy$1,001 - $15,0002025-09-29
Ro Khanna🏢 House$MET▼ Sell$1,001 - $15,0002025-08-26
Ro Khanna🏢 House$MET▼ Sell$1,000 - $15,0002025-08-26
Gilbert Cisneros🏢 House$MET▼ Sell$1,001 - $15,0002025-08-06
Ritchie Torres🏢 House$MET▼ Sell$1,001 - $15,0002025-07-11
Ro Khanna🏢 House$MET▲ Buy$1,001 - $15,0002025-06-13
Sheldon Whitehouse🏛 Senate$MET▼ Sell$1,001 - $15,0002024-11-19
Thomas R. Carper🏛 Senate$MET▼ Sell$1,001 - $15,0002024-01-17
Ro Khanna🏢 House$MET▲ Buy$1,001 - $15,0002023-10-31
Sheldon Whitehouse🏛 Senate$MET▼ Sell$1,001 - $15,0002023-09-20
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSYKMET
Forward yield1.04%3.33%
Annual dividend / share$3.40$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR46.2%23%
Portfolio after 10y$43.3K$41.3K
Annual income after 10y$8,282.98$4,879.85
Total dividends collected$21.0K$18.1K
Payment frequencyquarterlyquarterly
SectorHealthcareFinancials
Analyst consensusBuyBuy
Analyst price target$428.67$96.83

Year-by-year: SYK vs MET ($10,000, DRIP)

YearSYK PortfolioSYK Income/yrMET PortfolioMET Income/yrGap
1$10,852$152.43$11,109$408.98$257.00MET
2$11,838$226.03$12,409$522.27$571.00MET
3$13,004$336.89$13,948$670.62$944.00MET
4$14,420$505.63$15,791$866.52$1.4KMET
5$16,195$766.09$18,024$1,127.71$1.8KMET
6$18,504$1,175.64$20,765$1,479.66$2.3KMET
7$21,635$1,835.40$24,179$1,959.61$2.5KMET
8$26,082$2,932.10$28,494$2,622.90$2.4KMET
9$32,737$4,829.68$34,042$3,553.25$1.3KMET
10← crossover$43,312$8,282.98$41,305$4,879.85+$2.0KSYK

SYK vs MET: Complete Analysis 2026

SYKHealthcare

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Full SYK Calculator →

METFinancials

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; and pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.

Full MET Calculator →
📬

Get this SYK vs MET comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SYK vs SCHDSYK vs JEPISYK vs OSYK vs KOSYK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.